Multi-modality Neuro-Monitoring: Conventional Clinical Trial Design

Alexandros L. Georgiadis; Yuko Y. Palesch; David Zygun; J. Claude Hemphill; Claudia S. Robertson; Peter D. Leroux; Jose I. Suarez

doi:10.1007/s12028-015-0134-9

Multi-modality Neuro-Monitoring: Conventional Clinical Trial Design

Alexandros L. Georgiadis, Yuko Y. Palesch, David Zygun, J. Claude Hemphill, Claudia S. Robertson, Peter D. Leroux, Jose I. Suarez

Research output: Contribution to journal › Article › peer-review

Abstract

Multi-modal monitoring has become an integral part of neurointensive care. However, our approach is at this time neither standardized nor backed by data from randomized controlled trials. The goal of the second Neurocritical Care Research Conference was to discuss research priorities in multi-modal monitoring, what research tools are available, as well as the latest advances in clinical trial design. This section of the meeting was focused on how such a trial should be designed so as to maximize yield and avoid mistakes of the past.

Original language	English (US)
Pages (from-to)	369-377
Number of pages	9
Journal	Neurocritical care
Volume	22
Issue number	3
DOIs	https://doi.org/10.1007/s12028-015-0134-9
State	Published - Jun 1 2015
Externally published	Yes

Keywords

Intracranial pressure
Multi-modal monitoring
Neurocritical care
Randomized controlled trials

ASJC Scopus subject areas

Clinical Neurology
Critical Care and Intensive Care Medicine

Access to Document

10.1007/s12028-015-0134-9

Cite this

@article{dcb9166c55a84500a7054e41d30b425b,

title = "Multi-modality Neuro-Monitoring: Conventional Clinical Trial Design",

abstract = "Multi-modal monitoring has become an integral part of neurointensive care. However, our approach is at this time neither standardized nor backed by data from randomized controlled trials. The goal of the second Neurocritical Care Research Conference was to discuss research priorities in multi-modal monitoring, what research tools are available, as well as the latest advances in clinical trial design. This section of the meeting was focused on how such a trial should be designed so as to maximize yield and avoid mistakes of the past.",

keywords = "Intracranial pressure, Multi-modal monitoring, Neurocritical care, Randomized controlled trials",

author = "Georgiadis, {Alexandros L.} and Palesch, {Yuko Y.} and David Zygun and Hemphill, {J. Claude} and Robertson, {Claudia S.} and Leroux, {Peter D.} and Suarez, {Jose I.}",

note = "Funding Information: The Second Neurocritical Care Research Conference was funded by the National Institutes of Health (NINDS) (R13 NS077610, PI: Suarez JI), the Integra Foundation, and the Baylor St Luke{\textquoteright}s Medical Center in Houston, TX. Publisher Copyright: {\textcopyright} 2015, Springer Science+Business Media New York.",

year = "2015",

month = jun,

day = "1",

doi = "10.1007/s12028-015-0134-9",

language = "English (US)",

volume = "22",

pages = "369--377",

journal = "Neurocritical care",

issn = "1541-6933",

publisher = "Humana Press",

number = "3",

}

TY - JOUR

T1 - Multi-modality Neuro-Monitoring

T2 - Conventional Clinical Trial Design

AU - Georgiadis, Alexandros L.

AU - Palesch, Yuko Y.

AU - Zygun, David

AU - Hemphill, J. Claude

AU - Robertson, Claudia S.

AU - Leroux, Peter D.

AU - Suarez, Jose I.

N1 - Funding Information: The Second Neurocritical Care Research Conference was funded by the National Institutes of Health (NINDS) (R13 NS077610, PI: Suarez JI), the Integra Foundation, and the Baylor St Luke’s Medical Center in Houston, TX. Publisher Copyright: © 2015, Springer Science+Business Media New York.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Multi-modal monitoring has become an integral part of neurointensive care. However, our approach is at this time neither standardized nor backed by data from randomized controlled trials. The goal of the second Neurocritical Care Research Conference was to discuss research priorities in multi-modal monitoring, what research tools are available, as well as the latest advances in clinical trial design. This section of the meeting was focused on how such a trial should be designed so as to maximize yield and avoid mistakes of the past.

AB - Multi-modal monitoring has become an integral part of neurointensive care. However, our approach is at this time neither standardized nor backed by data from randomized controlled trials. The goal of the second Neurocritical Care Research Conference was to discuss research priorities in multi-modal monitoring, what research tools are available, as well as the latest advances in clinical trial design. This section of the meeting was focused on how such a trial should be designed so as to maximize yield and avoid mistakes of the past.

KW - Intracranial pressure

KW - Multi-modal monitoring

KW - Neurocritical care

KW - Randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=84937763839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937763839&partnerID=8YFLogxK

U2 - 10.1007/s12028-015-0134-9

DO - 10.1007/s12028-015-0134-9

M3 - Article

C2 - 25832350

AN - SCOPUS:84937763839

SN - 1541-6933

VL - 22

SP - 369

EP - 377

JO - Neurocritical care

JF - Neurocritical care

IS - 3

ER -

Multi-modality Neuro-Monitoring: Conventional Clinical Trial Design

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this